METTL21B is a prognostic biomarker and potential therapeutic target in low-grade gliomas

Xin Shu; Xinquan Li; Xiaochen Xiang; Qiang Wang; Qingming Wu

doi:doi:10.18632/aging.203454

← Back

Research Paper Volume 13, Issue 16 pp 20661—20683

METTL21B is a prognostic biomarker and potential therapeutic target in low-grade gliomas

Figure 9. Construction of prognostic model of METTL21B along with other eEF1A associated methyltransferases. (A) Multivariate Cox model for 5 eEF1A associated methyltransferases and clinical features. (B) The nomogram for METTL21B, EEF1AKMT2, age and WHO grade.